Abstract
We evaluated self-collected vaginal human papillomavirus tests for cervical cancer screening and compared it with the specimens taken directly from the cervix in 247 patients at high-risk for cervical disease. The sample taken by the patient showed human papillomavirus DNA in a higher percentage than the sample taken by a doctor. Sensitivity of high-risk human papillomavirus types for high-grade cervical precursors (CIN 2/3) and invasive cervical cancers were 93% for both methods.
Publication types
-
Comparative Study
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Biopsy
-
Colposcopy
-
Curettage
-
DNA, Viral / analysis*
-
Evaluation Studies as Topic
-
Female
-
Humans
-
Mass Screening / instrumentation
-
Mass Screening / methods*
-
Neoplasm Invasiveness
-
Papillomaviridae / genetics*
-
Papillomaviridae / isolation & purification
-
Precancerous Conditions / diagnosis
-
Prospective Studies
-
Self-Examination
-
Sensitivity and Specificity
-
Uterine Cervical Dysplasia / diagnosis
-
Uterine Cervical Neoplasms / diagnosis*
-
Uterine Cervical Neoplasms / virology
-
Vaginal Smears / instrumentation
-
Vaginal Smears / methods*